+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automatic Immunohistochemical Staining Instrument Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081940
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Automatic Immunohistochemical Staining Instrument Market is projected to reach USD 1.04 Billion in 2026. It is expected to continue growing at a CAGR of 8.97%, reaching USD 1.78 Billion by 2032.

Automatic Immunohistochemical Staining Instruments: Executive Summary

Automatic immunohistochemical staining instruments standardize antibody application, incubation, washing, counterstaining, and slide handling in tissue diagnostics. Their value is tied to reproducibility, workflow control, labor efficiency, and integration with pathology information systems. Adoption is shaped by laboratory volume, staffing, reimbursement, validation requirements, assay menus, consumable compatibility, and access to technical support.

Automation Is Reshaping Tissue-Pathology Workflows

Laboratories are moving from manual, operator-dependent staining toward standardized platforms that improve process consistency and traceability. This shift is reinforced by rising case complexity, greater use of immunohistochemistry in tumor classification and biomarker assessment, and pressure to reduce turnaround-time variation. Instrument selection increasingly depends on open versus closed workflow design, throughput flexibility, quality-control features, remote monitoring, waste management, and interoperability with digital pathology systems.

Artificial Intelligence Strengthens Interpretation and Workflow Control

Artificial intelligence is influencing the market primarily through image analysis, quality assurance, case prioritization, and workflow orchestration rather than replacing staining automation itself. Algorithmic tools can support cellular quantification, biomarker scoring, tissue-region identification, and detection of potentially inadequate slides, while automated instruments provide the controlled precondition for consistent image acquisition. Effective deployment requires validated algorithms, representative training data, explainable outputs, cybersecurity, human oversight, and clear responsibility for diagnostic decisions.

Regional Adoption Reflects Infrastructure, Regulation, and Laboratory Maturity

North America is characterized by sophisticated pathology networks, strong demand for standardized biomarker testing, and attention to interoperability and compliance. Europe combines advanced laboratory capabilities with stringent regulatory and data-governance expectations, while the European Union emphasizes harmonized requirements alongside national reimbursement differences. Asia-Pacific spans highly automated urban centers and capacity-constrained settings, creating demand for scalable systems and dependable service networks. Latin America is influenced by unequal access to specialized pathology, import logistics, and public-sector procurement. The Middle East is investing in centralized diagnostic capacity and healthcare modernization, whereas Africa presents substantial opportunities for adaptable, service-supported deployment that addresses infrastructure, training, and maintenance constraints.

Economic and Security Alliances Shape Procurement Priorities

ASEAN laboratories often balance rapid modernization in leading healthcare hubs with uneven technical capacity across member states, making modularity and local support important. BRICS countries show diverse combinations of domestic manufacturing, public procurement, and large reference-laboratory networks. The European Union prioritizes regulatory alignment, quality systems, and cross-border evidence requirements. G7 markets generally emphasize validation, laboratory automation, cybersecurity, and integration with established clinical workflows. GCC countries are building centralized and technologically advanced healthcare systems, while NATO members commonly place additional emphasis on supply resilience, interoperability, and continuity of diagnostic operations.

Country Conditions Create Distinct Implementation Pathways

Australia and Canada favor quality-assured, networked laboratory models, with geography making service coverage and centralized testing relevant. The United States emphasizes high-throughput workflows, biomarker testing, compliance, and digital integration. Brazil and Mexico face mixed public-private demand, regional disparities, and procurement complexity. China and India combine expanding diagnostic capacity with strong interest in scalable automation and local support. Japan and South Korea emphasize precision, reliability, and advanced laboratory integration. France, Germany, Italy, Spain, and the United Kingdom operate within mature pathology environments where validation, reimbursement, regulatory compliance, and interoperability influence adoption. Russia’s deployment environment is shaped by procurement access, localization considerations, and service continuity.

Prioritize Interoperability, Validation, and Sustainable Service Delivery

Industry leaders should design instruments around modular throughput, transparent quality controls, broad assay compatibility, and straightforward integration with laboratory and digital pathology systems. Commercial and clinical strategies should segment laboratories by workload, staffing, infrastructure, and regulatory needs rather than applying a single configuration. Vendors and users should establish documented validation protocols, monitor reagent and instrument performance, and provide competency-based training. Service models should include preventive maintenance, remote diagnostics where permitted, spare-parts planning, cybersecurity controls, and continuity procedures. AI-enabled features should be introduced with clinical governance, bias testing, audit trails, and explicit human review.

Methodology: Evidence-Based Assessment of Automation Adoption

This executive summary uses a structured assessment of the automatic immunohistochemical staining instrument landscape, focusing on workflow requirements, laboratory operating conditions, regulatory context, technology integration, and geographic differences. Insights are derived from the supplied market definition and established industry factors relevant to pathology automation, including assay standardization, throughput, quality assurance, digital connectivity, workforce constraints, procurement models, and infrastructure readiness. No market estimates, market shares, forecasts, or company-specific claims are used.

Standardization and Connected Diagnostics Define the Strategic Agenda

Automatic immunohistochemical staining instruments are becoming central to reproducible, traceable, and scalable tissue-diagnostic workflows. The strongest strategic position will come from combining dependable automation with validated assays, interoperable software, responsive service, and responsible use of AI. Regional and country differences require tailored implementation models, but the underlying priorities are consistent: reliable quality, efficient operations, workforce support, regulatory readiness, and continuity of diagnostic access.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Automatic Immunohistochemical Staining Instrument Market, by Product Type
7.1. Introduction
7.2. Fully Automated
7.3. Semi Automated
8. Automatic Immunohistochemical Staining Instrument Market, by Technology
8.1. Introduction
8.2. Chromogenic
8.2.1. AP FAST RED
8.2.2. HRP DAB
8.3. Fluorescent
8.3.1. Multiplex
8.3.2. Single Color
9. Automatic Immunohistochemical Staining Instrument Market, by Application
9.1. Introduction
9.2. Infectious Diseases
9.2.1. Bacterial Infection
9.2.2. Viral Infection
9.3. Neurology
9.3.1. Alzheimer
9.3.2. Parkinson
9.4. Oncology
9.4.1. Breast Cancer
9.4.2. Colorectal Cancer
9.4.3. Lung Cancer
10. Automatic Immunohistochemical Staining Instrument Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Research Institutes
11. Automatic Immunohistochemical Staining Instrument Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Automatic Immunohistochemical Staining Instrument Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Automatic Immunohistochemical Staining Instrument Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Biocare Medical LLC
15.3. BioGenex Laboratories, Inc.
15.4. Candor Bioscience GmbH
15.5. Cell Signaling Technology, Inc.
15.6. CVision Technologies, Inc.
15.7. Danaher Corporation
15.8. Diagnostic BioSystems Inc.
15.9. Leica Biosystems Nussloch GmbH
15.10. Medite GmbH & Co. KG
15.11. Milestone Medical, Inc.
15.12. Roche Diagnostics GmbH
15.13. Sakura Finetek USA, Inc.
15.14. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Automatic Immunohistochemical Staining Instrument Market, Years Considered for the Study
FIGURE 2. Global Automatic Immunohistochemical Staining Instrument Market, Research Design
FIGURE 3. Global Automatic Immunohistochemical Staining Instrument Market, Research Framework
FIGURE 4. Global Automatic Immunohistochemical Staining Instrument Market, Data Triangulation
FIGURE 5. Global Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Automatic Immunohistochemical Staining Instrument Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Automatic Immunohistochemical Staining Instrument Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Automatic Immunohistochemical Staining Instrument Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Automatic Immunohistochemical Staining Instrument Market Segmentation & Coverage
TABLE 2. Global Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 3. Global Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Fully Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Fully Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Fully Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Semi Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Semi Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Semi Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 11. Global Chromogenic Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Chromogenic Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Chromogenic Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global AP FAST RED Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global AP FAST RED Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global AP FAST RED Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global HRP DAB Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global HRP DAB Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global HRP DAB Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Fluorescent Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Fluorescent Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Fluorescent Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Multiplex Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Multiplex Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Multiplex Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Single Color Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Single Color Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Single Color Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 30. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Bacterial Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Bacterial Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Bacterial Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Viral Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Viral Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Viral Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Alzheimer Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Alzheimer Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Alzheimer Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Parkinson Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Parkinson Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Parkinson Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. North America Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. North America Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 84. North America Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 85. North America Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 86. North America Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. North America Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 88. North America Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 89. North America Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 90. North America Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 95. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 96. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 98. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 99. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 100. Latin America Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 103. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 105. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 106. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 108. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 109. Europe Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 110. Europe Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 114. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 115. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 116. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 118. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 119. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 120. Middle East Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 125. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 126. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 128. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 129. Africa Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 130. Africa Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Global Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 136. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 137. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 139. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 140. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 141. ASEAN Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 146. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 147. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 149. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 150. GCC Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 151. GCC Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 155. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 156. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 157. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 159. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 160. European Union Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 161. European Union Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 166. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 167. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 169. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 170. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 171. BRICS Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 176. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 177. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 179. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 180. G7 Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 181. G7 Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 186. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 187. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 189. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 190. NATO Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 191. NATO Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Global Automatic Immunohistochemical Staining Instrument Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. United States Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 194. United States Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. United States Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. United States Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 197. United States Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 198. United States Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. United States Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 200. United States Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 201. United States Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 202. United States Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Canada Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 204. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 206. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 207. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 208. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 210. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 211. Canada Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 212. Canada Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Mexico Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 214. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 217. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 218. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 220. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 221. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 222. Mexico Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Brazil Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 224. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 227. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 228. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 230. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 231. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 232. Brazil Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 234. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 237. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 238. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 240. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 241. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 242. United Kingdom Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Germany Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 244. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 247. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 248. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 250. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 251. Germany Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 252. Germany Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. France Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 254. France Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. France Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. France Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 257. France Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 258. France Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. France Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 260. France Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 261. France Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 262. France Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Russia Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 264. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 267. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 268. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 270. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 271. Russia Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 272. Russia Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Italy Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 274. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 276. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 277. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 278. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 280. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 281. Italy Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 282. Italy Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Spain Automatic Immunohistochemical Staining Instrument Market Size, 2017-2032 (USD Million)
TABLE 284. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 285. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Technology, 2017-2032 (USD Million)
TABLE 286. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Chromogenic, 2017-2032 (USD Million)
TABLE 287. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Fluorescent, 2017-2032 (USD Million)
TABLE 288. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 290. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 291. Spain Automatic Immunohistochemical Staining Instrument Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 292. Spain Automatic Immunohistochemical Staining Instrument Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. China Automatic Immunohistochemical Staining

Companies Mentioned

  • Agilent Technologies, Inc.
  • Biocare Medical LLC
  • BioGenex Laboratories, Inc.
  • Candor Bioscience GmbH
  • Cell Signaling Technology, Inc.
  • CVision Technologies, Inc.
  • Danaher Corporation
  • Diagnostic BioSystems Inc.
  • Leica Biosystems Nussloch GmbH
  • Medite GmbH & Co. KG
  • Milestone Medical, Inc.
  • Roche Diagnostics GmbH
  • Sakura Finetek USA, Inc.
  • Thermo Fisher Scientific Inc.